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Abstract
Background: There is increasing evidence that childhood vaccines have effects that extend beyond their target
disease. The objective of this study was to assess the effects of routine childhood vaccines on bacterial carriage in
the nasopharynx.
Methods: A cohort of children from rural Gambia was recruited at birth and followed up for one year. Nasopharyngeal
swabs were taken immediately after birth, every two weeks for the first six months and then every other month. The
presence of bacteria in the nasopharynx (Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus)
was compared before and after the administration of DTP-Hib-HepB and measles-yellow fever vaccines.
Results: A total of 1,779 nasopharyngeal swabs were collected from 136 children for whom vaccination data were
available. The prevalence of bacterial carriage was high: 82.2% S. pneumoniae, 30.6%, S.aureus, 27.8% H. influenzae.
Carriage of H. influenzae (OR = 0.36; 95% CI: 0.13, 0.99) and S. pneumoniae (OR = 0.25; 95% CI: 0.07, 0.90) were
significantly reduced after measles-yellow fever vaccination; while DTP-Hib-HepB had no effect on bacterial carriage.
Conclusions: Nasopharyngeal bacterial carriage is unaffected by DTP-Hib-HepB vaccination and reduced after
measles-yellow fever vaccination.
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Background
Measles vaccination campaigns conducted in sub-Saharan
Africa during the 1980s were associated with substantial
reductions (30-50%) in overall childhood mortality. The
effect was much larger than was anticipated from protec-
tion against measles, and it was suggested that measles
vaccine might confer benefits additional to its impact on
measles [1]. Observational studies and randomized trials
which compared mortality in vaccinated and unvaccinated
children have provided further data on the non-specific
effects of vaccines in countries where infant mortality is
high; diphtheria-tetanus-pertussis (DTP) vaccination was
associated with higher childhood mortality [1,2], and the
benefits of measles vaccination and adverse effects of DTP
were greater in girls than boys [2]. However, it remains
unclear how vaccines might contribute to, or prevent,
deaths unrelated to the target disease. One possibility is
that the vaccines alter susceptibility to bacterial diseases,
which are a common cause of child mortality in Africa [3].
Asymptomatic bacterial infections are common in
healthy infants and children, especially in developing
countries, and a high prevalence of carriage is associated
with high burdens of invasive bacterial diseases, which
suggests that carriage is a pre-cursor for invasive bacterial
disease [4-6]. We are not aware of any previous study that
has assessed a possible effect of routine infant vaccination
on the risk of bacterial carriage. We have therefore ana-
lyzed the association between infant vaccinations and
nasopharyngeal carriage of Streptoccocus pneumoniae,
Haemophilus influenzae and Staphylococcus aureus, three
pathogens commonly associated with invasive disease and
mortality in infants and young children in Africa.
Methods
Ethics statement
Written parental consent was obtained from a parent or
guardian of all study participants. The original carriage
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study was approved by the joint Medical Research Council
(MRC)/Gambia Government Ethics Committee and by
the ethics committee of the London School of Hygiene &
Tropical Medicine. The retrospective collection of vaccin-
ation dates was approved by the joint Medical Research
Council (MRC)/Gambia Government Ethics Committee.
Participants and study design
Between December 17th, 2003, and June 16th, 2005, new-
born infants were recruited from 21 villages in the Sibanor
region, The Gambia in preparation for a cluster ran-
domized trial of a seven-valent pneumococcal conjugate
vaccine [7,8]. Nasopharyngeal swabs (NPS) were taken as
soon as possible after birth, every two weeks for the first
six months, and then every other month until the first
birthday.
As part of the Expanded Programme on Immunisation
(EPI), children were scheduled to receive BCG at birth
or soon afterwards, followed by three doses of a com-
bined DTP, H. influenzae type b (Hib) and hepatitis B
vaccine (starting at two months and then monthly).
Measles and yellow fever vaccines were scheduled at the
age of 9 months. Poliomyelitis vaccine was administered
at birth, and then at two, three, four, 9 and 12 months of
age. The dates of all vaccinations, with the exception of
those for polio, were retrospectively transcribed in 2012
by study field assistants from either the welfare card of
the participants or health centre records.
Sample collection
Nasopharyngeal swabs (NPSs) were collected from the
posterior wall of the nasopharynx using a calcium alginate
swab, and immediately inoculated into vials containing
skim-milk-tryptone-glucose-glycerol (STGG) transport
medium; these were then placed in a cold box before
being transferred to the MRC Unit Fajara laboratories
within eight hours of collection. The procedure was con-
ducted in accordance with the World Health Organization
protocol for evaluation of pneumococcal carriage [9].
Inoculated vials were vortexed for a minimum of 20
seconds to homogenize the bacterial suspension before
being stored at −70°C until they were tested in batches.
Laboratory procedures
The samples were analyzed for the presence of S. pneu-
moniae as part of the original study by Hill et al. [7]. In
2012, the STGG samples were thawed on ice, vortexed
briefly, and inoculated onto agar plates for the isolation of
S. aureus, H. influenzae and β-haemolytic streptococci.
Streptococcus pneumoniae. Ten μl of a thawed STGG
sample were plated onto gentamicin blood agar and
incubated for 18-24 hours at 35°C in 5% CO2. Pneumo-
coccal identification was based on colony morphology,
and conventional methods of characterization (optochin
susceptibility and bile solubility assays) [10]. Serotyping
was performed with capsular and factor typing sera
(Statens Serum Institut) using the latex agglutination
technique [10]. Isolates with equivocal serotype results
were confirmed by the Quellung reaction.
Staphylococcus aureus. Fifty μl of thawed STGG sample
were plated onto mannitol salt agar plates and incubated
for 48 hours at 37°C in ambient air. The plates were exam-
ined for yellow or white colonies typical of staphylococci,
and subcultured onto blood agar plates to obtain pure
growth. A catalase test was performed on all suspected
colonies, followed by coagulase testing using the Remel
Staphaurex® Plus kit (Oxoid cat# OXR30950201), to con-
firm S. aureus.
Haemophilus influenzae. Fifty μl of thawed STGG sam-
ple were plated onto bacitracin supplemented chocolate
agar plates and incubated at 37°C with 5% CO2. After
18-24 hours, the plates were examined for colourless or
grey, translucent or opaque colonies, and these were
sub-cultured onto chocolate agar. An oxidase test was
performed on all presumptive H. influenzae colonies.
Oxidase positive colonies were screened using X and V
factors to confirm the isolation of H.influenzae. Con-
firmed isolates were further serotyped using BD DifcoTM
Hi-antisera Type a-f.
Beta-haemolytic streptococci. Fifty μl of thawed STGG
sample were plated onto crystal violet supplemented
blood agar for 20-24 hours and incubated at 37°C in
ambient air. Plates were examined for colonies showing
transparent zones around them (beta-haemolysis); these
were sub-cultured onto blood agar plates to obtain pure
growth. Beta-haemolytic and catalase negative isolates
were subjected to Bacitracin testing and classified using
the slidex streptococcal grouping kit (Biomerieux, cat#
58810) into Lancefield groups A, B, C, D, F or G.
Statistical analysis
We analysed the prevalence of bacterial carriage in each
decile of age – i.e., the ages at which samples were taken
were split into 10 groups of equal size with the first
group containing the 10% of samples taken at the youn-
gest ages, the second group containing those taken at
the next youngest 10%, and so on. Confidence intervals
for these prevalence estimates were adjusted for clustering
at the village level.
In addition, we used logistic regression models, in
which age was included as a restricted cubic spline func-
tion, to estimate age-prevalence curves. Restricted cubic
splines are used to model the relationship between an
outcome (carriage) and a continuous predictor (age). Spe-
cifically, the restricted cubic spline splits the continuous
predictor into categories and uses separate cubic relation-
ships to model the association within each category,
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except in the first and last category where a linear rela-
tionship is assumed [11].
To estimate the effect of DTP (first dose and com-
bined with Hib and hepatitis B) vaccination on carriage,
we compared the prevalence of bacterial carriage before
and after DTP vaccination. We excluded samples collected
before BCG or after measles-yellow fever vaccination, and
samples collected after the first DTP-Hib-HepB vaccin-
ation were divided into those collected <4 weeks or ≥4
weeks after vaccination to determine whether any effect of
DTP-Hib-HepB changed with time since vaccination.
Confounding attributable to variability between individ-
uals was eliminated by estimating the effect of vaccination
on bacterial carriage within individuals using conditional
logistic regression. Samples before DTP-Hib-HepB vaccin-
ation were necessarily taken at a younger age than those
after DTP-Hib-HepB vaccination and to adjust for the
potential confounding effect of age we included age in the
model as a restricted cubic spline function with six knots
(i.e., six cut points), as recommended by Harrell [12],
located at percentiles 5, 23, 41, 59, 95. Potential confound-
ing due to seasonality was accounted for by including
calendar time in the model as a restricted cubic spline
function with three knots at percentiles 10, 50 and 90.
The effect of measles-yellow fever vaccination was esti-
mated by comparing samples collected after BCG +
DTP-Hib-HepB with those obtained after BCG + DTP-
Hib-HepB +measles-yellow fever vaccination. Conditional
logistic regression models were used to estimate odds
ratios as described above for DTP-Hib-HepB.
All analyses were conducted using Stata version 12.1
(StataCorp).
Results
Demographic data
There were 251 live births in the study population during
the 18-month recruitment period, 237 (94.4%) infants
were recruited into the study, and at least one sample was
collected from 236 infants. The analyses reported here are
based on the cohort of 136 (57.6%) infants for whom all
vaccination dates were recorded; children who missed one
or more vaccinations, or who did not have a complete rec-
ord of vaccinations based on their welfare card and clinic
records, were excluded. Slightly less than half of the co-
hort (46.3%) was female and the predominant ethnicities
were Jola (67.6%) and Madinka (22.1%). The median
(IQR) birth weight, recorded by the study team at the
mother’s home or in the health facility, was 3.9kg (3.4,
4.4), and 3.7% of infants were of low birthweight (<2.5kg).
Age at vaccination
There was variability in the ages at which each of the
vaccines was administered (Figure 1). The median (IQR)
age of vaccination was 1.8 weeks (1.4, 2.3) for BCG, 11.7
weeks (10.0, 13.9) for DTP-Hib-Hep B (first vaccination),
42.8 weeks (40.4, 46.4) for measles and 43.0 (40.6, 47.4)
for yellow fever. Yellow fever vaccine was generally given
concurrently with measles, but was occasionally given
later if it was not available at the clinic at the time of
measles vaccination. Because the age range over which
BCG was given was small, we have not included analyses
of carriage data before and after BCG vaccination.
Bacterial carriage and its age-profile
A total of 1,779 samples were collected. The number
collected from each child varied from 2 to 17, with a
median of 14 (IQR: 11, 15) samples per child. The propor-
tions of samples positive for S. pneumoniae, H. influenzae,
S. aureus and Group B streptococcus (GBS) were 82.2%,
27.8%, 30.6% and 1.6%, respectively. GBS was excluded
from further analyses because of its low prevalence.
Among the S. pneumoniae positive samples, the most
common serotypes were 6B (15.0%), 19F (11.4%), 14
(9.3%), 6A/C (7.6%) and 19A (5.1%). Thirty-seven isolates
of H. influenzae were serotyped: 2 (5.4%) were serotype E,
1 (2.7%) serotype F and the rest (n = 34) were non-
typeable.
The prevalence of S. aureus declined from approxi-
mately 70% immediately after birth to 20% at 20 weeks
and then remained constant until the end of follow up
at 1 year (Figure 2). In contrast, the prevalences of S.
pneumoniae and H. influenzae increased after birth, to
reach a plateau between 10 and 20 weeks of approximately
85% and 35%, respectively.
Vaccination and bacterial carriage
Table 1 shows the prevalence of carriage before and after
the first dose of DTP-Hib-Hep B vaccination and the
odds ratios comparing prevalence post and pre vaccin-
ation after adjusting for age and calendar time. There
Figure 1 Box and whisker plot for ages at vaccination (first vaccine
dose in the case of DTP-Hib-Hep B). The “box” represents the
interquartile range (IQR) and the whiskers span all points within 1.5 IQR.
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was no evidence of a significant change in the preva-
lence of carriage for any of the three bacteria. Table 2
shows similar data for measles-yellow fever vaccination.
Carriage of S. pneumoniae and H. influenzae decreased
after measles-yellow fever vaccination. For H. influenzae
the greatest reduction occurred in the first month after
vaccination, while for S. pneumonia the reduction was
similar regardless of when samples were collected.
Measles-yellow fever vaccination had no effect on the
prevalence of S. aureus. The analyses were repeated
separately for boys and girls, but there was no signifi-
cant difference between the findings for each gender
(data not shown). We also conducted analyses where
age was modeled as a categorical variable using deciles,
the results of these analyses were similar to those pre-
sented in Tables 1 and 2 where age was modeled using
spline functions.
Discussion
To our knowledge, this is the first report that measles-
yellow fever vaccination may reduce the bacterial carriage
of some pathogens. The nasopharynx acts as a reservoir
for a number of pathogenic bacteria and asymptomatic
nasopharyngeal carriage, even if transitory, is a necessary
preliminary step in the progression to severe disease.
The relationship between bacterial carriage and disease
is illustrated by a parallel decrease in carriage of vaccine
serotypes and invasive pneumococcal disease following
the introduction of pneumococcal conjugate vaccines [6].
Changes in the prevalence of bacterial carriage are, there-
fore, likely to affect the incidence of severe disease and
mortality, although our study was too small to assess these
outcomes.
Our findings support a possible protective effect of
measles-yellow fever vaccination against disease due to
S. pneumoniae and H. influenzae, which would be com-
patible with a non-specific effect of measles vaccination
on diseases other than measles. In contrast, our failure to
find an association between DTP-Hib-HepB vaccination
Figure 2 The prevalence of bacterial carriage during follow up.
The prevalence is given in each decile of age with 95% confidence
intervals, the lines are predictions from a logistic regression where
the effect of age on carriage is modeled using spline functions.
Table 1 Bacterial carriage before and after the first dose of DTP-Hib-Hep B vaccination
Period No. samples Prevalence (%) OR* (95% CI) p-value
S. pneumoniae
Pre vaccination† 518 86.6
Post vaccination (<4wks) 201 87.6 0.99(0.39,2.49) 0.975
Post vaccination (4 + wks) 767 90.4 1.83(0.65,5.15) 0.252
Post vaccination (All) 968 89.8 1.36(0.65,2.86) 0.411
H. influenzae
Pre vaccination† 512 33.3
Post vaccination (<4wks) 199 30.2 1.03(0.57,1.86) 0.923
Post vaccination (4 + wks) 753 34.4 1.48(0.74,2.97) 0.270
Post vaccination (All) 952 33.5 1.02(0.62,1.69) 0.928
S. aureus
Pre vaccination† 512 28.4
Post vaccination (< 4wks) 199 29.6 0.97(0.54,1.74) 0.924
Post vaccination (4 + wks) 753 19.0 0.86(0.41,1.79) 0.680
Post vaccination (All) 952 21.2 0.97(0.57,1.63) 0.897
Based on an analysis of 123 individuals. Samples collected post BCG compared with samples collected after the first DTP-Hib-Hep B vaccination and prior to
measles-yellow fever vaccination.
*OR adjusted for age and calendar time. Estimates from each model are based on different numbers of individuals because information is not contributed by
individuals whose carriage status is the same at all time points; estimates for S.pneumoniae, H. influenzae and S.aureus are based on 1062, 1388, 1398 samples
from 93, 125, 124 individuals.
† prevalence in samples collected after 10 weeks based on 142, 141 and 141 samples for S.pneumoniae, H. influenzae and S.aureus.
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and carriage of any of the three bacteria studied offers no
support to the hypothesis of a deleterious non-specific
effect of DTP vaccination [13]. It should be noted that
because measles vaccination was generally given with
yellow fever vaccination we cannot distinguish between
effects of the two vaccines, similarly DTP vaccination
was given with Hib and Hepatitis B vaccination so any
individual effects of these three vaccines also cannot be
distinguished.
The mechanisms underlying the observed non-specific
effect of measles-yellow fever vaccination on S.pneumo-
niae and H.influenzae carriage are unknown. The immune
response to measles vaccine is characterized by general-
ized immunosuppression, but also a strong Th-1 cytokine
pattern [14], which might impact on carriage. The live
attenuated yellow fever vaccine, YF-17D, activates the
innate immune system and induces a mixed T helper 1 and
T helper 2 cell profile [15]. Furthermore, an interaction
between YF-17D and dengue has been documented [16].
The vaccine effect was determined by comparing car-
riage status before and after vaccination. This approach is
different to that taken in previous observational studies
which have compared vaccinated and unvaccinated chil-
dren; such estimates can be biased by differences in the
socio-economic or underlying health status of the two
groups [17]. By comparing samples collected within the
same children we eliminate bias of this kind, although
the estimates are still vulnerable to time-dependent
confounders such as age, season, delayed vaccination or
use of antibiotics [18]. Seasonality has a limited role as
a confounder since births and vaccinations occurred at
a uniform rate throughout the study. Age is potentially
an important confounder but the prevalence of H.
influenzae and S. pneumoniae remained approximately
constant after10 weeks, so this is unlikely to explain the
observed reduction after measles-yellow fever vaccine;
furthermore we were able to control for the effect of
age using regression models. It is unclear to what extent
delayed vaccination and the use of antibiotics might
confound our estimates. Carriage increases during a
respiratory infection and if vaccination is delayed when
a child is sick then this might explain the decrease in
bacterial carriage [18]; alternatively, if a sick child is
given antibiotics at the time of vaccination then this
will also lead to a decrease in bacterial carriage.
A limitation of our study design is that the vaccine
effects could not be evaluated separately. We are only
able to report the effect of DTP-Hib-HepB in children
who have been vaccinated with BCG, and the effect of
measles-yellow fever vaccine in children previously vac-
cinated with BCG and DTP-Hib-HepB. In addition, our
analysis cannot differentiate whether the effect observed
is due to vaccines that are concurrently given - measles
is given with yellow fever and polio is administered with
BCG, DTP and measles.
We excluded from the analysis individuals for whom
dates of vaccination were missing, either because they did
not receive the vaccination, or because the information
was missing from the welfare card or clinic records. It is
possible that children excluded from the analysis are
Table 2 Bacterial carriage before and after measles-yellow fever vaccination
Period No. samples Prevalence (%) OR* (95% CI) p-value
S. pneumoniae
Pre vaccination† 968 93.8
Post vaccination (< 4wks) 48 83.3 0.19(0.05,0.72) 0.014
Post vaccination (4 + wks) 107 91.6 0.19(0.03,1.35) 0.098
Post vaccination (All) 155 89.0 0.25(0.07,0.90) 0.033
H. influenzae
Pre vaccination† 952 41.1
Post vaccination (< 4 wks) 47 14.9 0.36(0.13,0.99) 0.047
Post vaccination (4 + wks) 106 29.2 0.80(0.32,1.97) 0.625
Post vaccination (All) 153 24.8 0.53(0.25,1.12) 0.097
S. aureus
Pre vaccination† 952 18.9
Post vaccination (<4 wks) 46 15.2 1.15(0.36,3.70) 0.816
Post vaccination (4 + wks) 106 17.0 1.04(0.32,3.31) 0.951
Post vaccination (All) 152 16.4 1.05(0.41,2.73) 0.916
Samples collected after vaccination with DTP-Hib-Hep B compared with samples post measles-yellow fever.
*OR adjusted for age and calendar time. Estimates from each model are based on different numbers of individuals because information is not contributed by
individuals whose carriage status is the same at all time points; estimates for S.pneumoniae, H. influenzae and S.aureus are based on 641, 1039, 922 samples from
70, 119, 104 individuals.
†prevalence after 35 weeks based on 97, 95 and 95 samples for S.pneumoniae, H. influenzae and S.aureus.
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systematically different from those included (e.g., they
might have poorer and less educated mothers), and the
association between vaccination and bacterial carriage
might be different in those excluded.
Conclusions
In conclusion, our study provides preliminary evidence
for a non-specific effect of measles and/or yellow fever
vaccines on bacterial carriage of important bacterial path-
ogens, which warrants further investigation. Randomized
clinical trials would be the best way to test our findings,
for example, by examining the effects on carriage of differ-
ent vaccination schedules.
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